SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-024960
Filing Date
2022-10-27
Accepted
2022-10-27 17:00:21
Documents
13
Period of Report
2022-10-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20221027_8k.htm   iXBRL 8-K 26908
  Complete submission text file 0001437749-22-024960.txt   159005

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA stab-20221026.xsd EX-101.SCH 3602
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20221026_def.xml EX-101.DEF 11533
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20221026_lab.xml EX-101.LAB 15415
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20221026_pre.xml EX-101.PRE 11689
7 EXTRACTED XBRL INSTANCE DOCUMENT cbli20221027_8k_htm.xml XML 2567
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 221337980
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences